Table 1.
Demographic and clinical characteristics.
| Demographic Details | All patients (N = 174) | WOC (N = 85) | WC (N = 89) | P* | |
|---|---|---|---|---|---|
| Age [M, MD (R)] | 41.51, 38 (18–87) | 36.72, 33 (19–83) | 46.08, 42 (18–87) | <0.001 | |
| BMI [M, MD (R)] | 27.69, 26.05 (16.9–50.46) | 24.29, 24 (18.46–29.6) | 30.93,30.96 (16.9–50.46) | <0.001 | |
| BMI>30 N (%) | 52 (29.82) | 20 (23.52) | 32 (35.95) | ||
| Sex N (%) | Female | 46 (26.44) | 20 (23.53) | 26 (29.21) | 0.3954 |
| Male | 128 (73.56) | 65 (76.47) | 63 (70.79) | ||
| Marital status N (%) | Partnered | 18 (10.34) | 10 (11.76) | 8 (8.99) | 0.5478 |
| Single | 156 (89.66) | 75 (88.24) | 81 (91.01) | ||
| Accommodation N (%) | Homeless | 32 (18.39) | 17 (20) | 15 (16.85) | 0.287 |
| HPL | 142 (81.60) | 68 (80) | 74 (83.14) | ||
| Ethnicity/Race N (%) | AA | 29 (16.67) | 13 (15.29) | 16 (17.98) | 0.4900 |
| Asian | 5 (2.87) | 4 (4.71) | 1 (1.12) | ||
| Hispanic | 40 (22.99) | 18 (21.18) | 22 (24.72) | ||
| White | 100 (57.47) | 50 (58.82) | 50 (56.18) | ||
| Smoker N (%) | Current | 76 (43.68) | 33 (38.82) | 43 (48.31) | 0.2070 |
| Non-smoker | 98 (56.32) | 52 (61.18) | 46 (51.69) | ||
| SUD N (%) | Meth | 51 (29.31) | 26 (30.59) | 25 (28.09) | 0.1445 |
| Cocaine | 6 (3.45) | 6 (7.06) | 0 (0) | ||
| Opioid | 14 (8.05) | 9 (10.59) | 5 (5.62) | ||
| ETOH | 18 (10.34) | 10 (11.76) | 8 (8.99) | ||
| Cannabis | 67 (38.51) | 40 (47.06) | 27 (30.34) | ||
| Psychiatric diagnosis N (%) | Schizophrenia | 45 (25.86) | 22 (25.88) | 23 (25.84) | 0.777 |
| SAD | 58 (33.33) | 33 (38.82) | 25 (28.08) | ||
| BPAD | 46 (25.43) | 22 (25.88) | 24 (26.96) | ||
| MDD | 12 (6.89) | 3 (3.52) | 9 (10.11) | ||
| Other | 13 (7.4) | 5 (5.88) | 8 (8.98) | ||
M = mean, MD = median, R = range, AA = African American, N = number of patients, HPL: has some form of place to live, % = percent, SUD = substance use disorder, Other = cognitive Disorder, anxiety disorder, psychosis NOS. WC=With comorbidity WOC = without comorbidity, SAD = schizoaffective disorder, BPAD = bipolar affective disorder. MDD = Major Depressive Disorder * Wilcoxon rank-sum test based 2-tail P-values for continuous variables and Chi-square 2-tail P-values comparing patients with and without comorbidities.